icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
4 Mar, 2021 14:35

Germany performs U-turn on AstraZeneca Covid-19 vaccine, recommending jab for over-65s as doses go unused and campaign falters

Germany performs U-turn on AstraZeneca Covid-19 vaccine, recommending jab for over-65s as doses go unused and campaign falters

Germany has recommended the administration of AstraZeneca’s Covid-19 vaccine to people aged over 65, marking a major change in the nation’s inoculation campaign which has so far seen a number of the Anglo-Swedish shots go unused.

“This is good news for older people who are waiting for a vaccine. They can now be vaccinated more quickly,” Health Minister Jens Spahn said on Thursday, adding “we will shortly issue a regulation implementing both recommendations.” 

Germany’s Standing Committee on Vaccination (StiKo) has advised that the two doses should be separated by a 12-week interval, mirroring the administration process in the UK, Spahn said. 

Also on rt.com France backs AstraZeneca Covid jab for older recipients, but only 24% of available doses have been administered

The decision comes as new real-world data emerged from the use of the AstraZeneca vaccine across the UK. Research published by Public Health England on Monday reinforced its effectiveness in the elderly, reducing hospitalization risk from Covid-19 by 80 percent among people aged 80 and over. 

A similar study in Scotland showed that four weeks after the first doses of the AstraZeneca vaccine were administered hospitalization risk fell by up to 94 percent. Meanwhile Pfizer’s jab was deemed to be less effective, reducing hospitalization by 85 percent. 

Also on rt.com EU lawmaker likens AstraZeneca to ‘unreliable second-hand car salesman’ as low European jab confidence hampers vaccine uptake

The move in Germany also comes after France made a similar decision to allow older people to receive the jab on Tuesday but chose to limit its use to those under the age of 75. 

Both France and Germany had previously limited its use to those under the age of 65 amid claims there was insufficient trial data to support its administration in older generations.

The shot has so far been notoriously underused across Europe. Last week, Elke Breitenbach, Berlin’s senator for social services, said that doses in the German capital are going to waste and called for the spare shots to be given to the city’s homeless. 

As of Monday, two thirds of the 1.4 million AstraZeneca jabs delivered to Germany remain in storage amid low uptake. To date, only eight percent of the country’s adult population have been vaccinated by one of the three jabs approved. In comparison, around 31 percent of British adults have been vaccinated.

If you like this story, share it with a friend!